Phibro Animal Health Corporation (NASDAQ:PAHC) VP Daniel M. Bendheim sold 1,443 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $40.05, for a total transaction of $57,792.15. Following the completion of the sale, the vice president now directly owns 300 shares of the company’s stock, valued at approximately $12,015. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.50% during midday trading on Wednesday, reaching $40.00. 55,178 shares of the company’s stock traded hands. The company has a 50-day moving average of $38.23 and a 200-day moving average of $32.54. The company has a market capitalization of $1.59 billion, a price-to-earnings ratio of 24.84 and a beta of 1.35. Phibro Animal Health Corporation has a one year low of $20.14 and a one year high of $40.25.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 1.00%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s payout ratio is 24.69%.

TRADEMARK VIOLATION WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/insider-selling-phibro-animal-health-corporation-pahc-vp-sells-1443-shares-of-stock/1496799.html.

A number of equities research analysts have recently issued reports on PAHC shares. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a research note on Thursday, May 11th. BidaskClub raised shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Piper Jaffray Companies set a $35.00 price objective on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, Credit Suisse Group cut shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and upped their price objective for the company from $29.00 to $36.00 in a research note on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Phibro Animal Health Corporation has an average rating of “Hold” and a consensus price target of $30.50.

Hedge funds and other institutional investors have recently bought and sold shares of the company. State of Alaska Department of Revenue raised its position in Phibro Animal Health Corporation by 80.9% in the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after buying an additional 1,650 shares during the last quarter. Mason Street Advisors LLC raised its position in Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock valued at $122,000 after buying an additional 286 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its position in Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. KBC Group NV purchased a new position in Phibro Animal Health Corporation during the second quarter valued at approximately $166,000. Finally, Victory Capital Management Inc. raised its position in Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock valued at $129,000 after buying an additional 2,021 shares during the last quarter. 47.64% of the stock is owned by institutional investors.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.